Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells

Ovarian cancer is an aggressive and lethal cancer usually treated by cytoreductive surgery followed by chemotherapy. Unfortunately, after an initial response, many patients relapse owing mainly to the development of resistance against the standard chemotherapy regime, carboplatin/paclitaxel, which i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Catanzaro, Daniela, Nicolosi, Silvia, Cocetta, Veronica, Salvalaio, Marika, Pagetta, Andrea, Ragazzi, Eugenio, Montopoli, Monica, Pasut, Gianfranco
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908290/
https://ncbi.nlm.nih.gov/pubmed/29682189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24708
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi